A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...

A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...

The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to ...

Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were ...

Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

The news outlet is pushing the Commission to release text messages that the E.U.’s top official and Pfizer exchanged as they ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

Dr. Mehmet Oz, a heart-surgeon-turned-television star, lost a 2022 bid for Senate in Pennsylvania as a Republican, even ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Heidi Chen is a "celebrated and well-respected business leader and general counsel who brings extensive industry experience ...